Transaction · 0001193125-26-355560

Robb Gary Charles

Robb Gary Charles, CBO, reported an open-market or private sale at CORCEPT THERAPEUTICS INC involving 10000.000000 shares for an estimated $1162572.00. Reported holdings after the transaction were 39716.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

Open-market sellSEC transaction code SCBO
CORTCORCEPT THERAPEUTICS INC
Filing timeAug 18
Trade dateAug 17, 2026
Filing · SECView on SEC
InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
$118.10
Pre-filing
1mo ago -23.4%1w ago -3.3%1d ago -3.1%
Returns since
7d +3.9%30d -4.0%90d -4.0%180d -4.0%1y -4.0%

CORT price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
CORT since 2026-08-18Filed 16 days ago · 30 days of pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Sell
Code S
Identifier
0001193125-26-355560
Common Stock
Transaction date
Aug 17, 2026
Filed Aug 18, 2026, 08:30 PM · 1d delay
Shares
10.0k sh
$11.6k per share
Estimated value
-$116M
Computed from shares × price
Holdings after
39.7k sh
Indirect · Gary Charles Robb TTE Robb Revocable Trust

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M
Cluster Selling Large Holdings Reduction Large Sale
+4score
Filing-only score

+4

Compact filing score computed from stored Form 4 facts. Version v1.

Neutral filing signal

This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

Chief Business Officer

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    Includes 251 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 2, 2025, 224 shares underlying unvested restricted stock awards granted to th…

  2. F2

    Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $116.00 to $116.54 per share. Information on the exact number of shares sold at each…

  3. F3

    These shares are held by Gary Charles Robb TTE Robb Revocable Trust of which the Reporting Person is trustee.

  4. F4F5(2 footnotes)

    These shares are held by a child of the Reporting Person through a custodial account under the Uniform Transfers to Minors Act for which the Reporting Person is custodian.

Original filing · 0001193125-26-355560
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

CORT